We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
+13.19%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$15.4B
AUM Growth
+$1.83B
Cap. Flow
+$159M
Cap. Flow %
1.03%
Top 10 Hldgs %
4.58%
Holding
4,279
New
1,019
Increased
1,194
Reduced
1,089
Closed
766

Top Buys

Rank Stock Value
1
SNPS icon
Synopsys
SNPS
+$56.4M
2
SLB icon
SLB Ltd
SLB
+$44.8M
3
MU icon
Micron Technology
MU
+$42.1M
4
SBUX icon
Starbucks
SBUX
+$39.4M
5
BMY icon
Bristol-Myers Squibb
BMY
+$39.3M

Top Sells

Rank Stock Value
1
MCD icon
McDonald's
MCD
+$79.9M
2
ELV icon
Elevance Health
ELV
+$74.4M
3
ADBE icon
Adobe
ADBE
+$63.6M
4
NKE icon
Nike
NKE
+$56.7M
5
DG icon
Dollar General
DG
+$51.8M

Sector Composition

Rank Sector Weight
1 Technology 11.72%
2 Consumer Discretionary 8.94%
3 Healthcare 6.55%
4 Industrials 6.04%
5 Financials 5.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LAC
3101
Lithium Americas
LAC
$1.18B
$141K ﹤0.01%
+21,936
New +$163K
RVNC
3102
CALL
DELISTED
Revance Therapeutics, Inc.
RVNC
$140K ﹤0.01%
15,900
-6,600
-29% -$54.1K
BALY icon
3103
Bally's
BALY
$635M
$140K ﹤0.01%
10,012
-104,065
-91% -$1.17M
PRCH icon
3104
Porch Group
PRCH
$1.79B
$139K ﹤0.01%
+45,177
New +$63.5K
RCEL icon
3105
Avita Medical
RCEL
$254M
$138K ﹤0.01%
+10,067
New +$115K
TEF
3106
DELISTED
Telefonica
TEF
$137K ﹤0.01%
+35,146
New +$141K
MTUS icon
3107
Metallus
MTUS
$901M
$137K ﹤0.01%
5,839
-47,798
-89% -$1M
LILAK icon
3108
Liberty Latin America Class C
LILAK
$1.66B
$137K ﹤0.01%
+20,513
New +$133K
NUVB icon
3109
Nuvation Bio
NUVB
$2.24B
$137K ﹤0.01%
90,604
+74,855
+475% +$96.3K
STEM icon
3110
PUT
Stem
STEM
$52.8M
$136K ﹤0.01%
1,755
-11,865
-87% -$818K
VTRS icon
3111
CALL
Viatris
VTRS
$18.7B
$135K ﹤0.01%
12,500
– –
FIRY
3112
Firy Inc
FIRY
$160M
$135K ﹤0.01%
+21,679
New +$121K
DERM icon
3113
Journey Medical
DERM
$174M
$135K ﹤0.01%
+23,438
New +$104K
BMA icon
3114
Banco Macro
BMA
$5.13B
$132K ﹤0.01%
4,597
-40,217
-90% -$917K
HIPO icon
3115
Hippo Holdings
HIPO
$881M
$131K ﹤0.01%
+14,418
New +$120K
ELAN icon
3116
CALL
Elanco Animal Health
ELAN
$11.4B
$131K ﹤0.01%
8,800
-29,800
-77% -$338K
MNRO icon
3117
Monro
MNRO
$365M
$131K ﹤0.01%
4,455
-78,916
-95% -$2.22M
AVDL
3118
DELISTED
Avadel Pharmaceuticals
AVDL
$131K ﹤0.01%
9,247
-9,338
-50% -$110K
ABOS icon
3119
Acumen Pharmaceuticals
ABOS
$178M
$130K ﹤0.01%
+33,905
New +$101K
SACH
3120
Sachem Capital Corp
SACH
$38.6M
$130K ﹤0.01%
+34,752
New +$124K
PTEN icon
3121
CALL
Patterson-UTI
PTEN
$4.22B
$130K ﹤0.01%
+12,000
New +$146K
MRAI
3122
DELISTED
Marpai, Inc. Class A Common Stock
MRAI
$130K ﹤0.01%
+74,039
New +$85.9K
RXRX icon
3123
Recursion Pharmaceuticals
RXRX
$1.8B
$129K ﹤0.01%
+13,104
New +$93.4K
BLUE
3124
DELISTED
bluebird bio
BLUE
$128K ﹤0.01%
+4,654
New +$284K
APPS icon
3125
Digital Turbine
APPS
$1.58B
$128K ﹤0.01%
18,690
+956
+5% +$5.34K
123 124
125
126 127

Similar funds

GIM
Glenmede Investment Management Philadelphia, Pennsylvania $20.7B AUM
ECM
Eisler Capital Management London, United Kingdom $22.6B AUM 9.36% 1-Year Est. Return
JFL
Jarislowsky, Fraser Ltd Montreal, Quebec, Canada $18.2B AUM 22.04% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
SF
Synovus Financial Columbus, Georgia $8.74B AUM 12.78% 1-Year Est. Return
WIM
Waverton Investment Management London, United Kingdom $7.77B AUM 25.07% 1-Year Est. Return
AIM
AXA Investment Managers Puteaux, France $37.1B AUM
SIG
Stonegate Investment Group Birmingham, Alabama $4.31B AUM 18.07% 1-Year Est. Return

Cubist Systematic Strategies's Q4 2023 Portfolio in Review

As of Q4 2023, Cubist Systematic Strategies held 4,279 positions worth $15.4B, up 14% from $13.5B the previous quarter. Its ten largest holdings account for 4.6% of the portfolio.

Cubist Systematic Strategies's Q4 2023 filing shows 1,019 new, 1,194 increased, 1,089 reduced and 766 closed positions. Its largest new stake was Synopsys: 110,316 shares worth $56.8M. The largest sale was McDonald's, an estimated $79.9M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Cubist Systematic Strategies's largest Q4 2023 buy was Synopsys: 110,316 shares worth $56.8M.
  • Cubist Systematic Strategies added most to Starbucks in Q4 2023, an estimated $39.4M increase.
  • Cubist Systematic Strategies's biggest Q4 2023 reduction was Elevance Health, cutting an estimated $74.4M.
  • Cubist Systematic Strategies fully exited McDonald's in Q4 2023, selling an estimated $79.9M.
  • Cubist Systematic Strategies's ten largest holdings make up 4.6% of its $15.4B portfolio in Q4 2023.
  • Cubist Systematic Strategies opened 1,019 new positions and closed 766 in Q4 2023.
  • Cubist Systematic Strategies's portfolio value rose 14% quarter-over-quarter to $15.4B.

Based on Cubist Systematic Strategies's 13F filing for Q4 2023, filed 14 Feb 2024.